Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. Dr. Stephen Hahn, the head of the Food and Drug Administration (FDA), said the agency is pushing forward “very aggressively” with the testing of potential therapies and treatments for the novel coronavirus.“It’s really important to stress that there are no FDA-approved therapies for COVID-19,” discussed on “America’s Newsroom” on Wednesday, ” but what we’re talking about is expediting, getting potentially positive therapies, therapies that could help out into hospitals, to doctors’ hands.”Also on Wednesday, the FDA announced a new program geared at expediting the development of potentially safe and effective life-saving treatments. The program, known as the Coronavirus Treatment Acceleration Program (CTAP), is using every tool at the agency’s disposal to bring new therapies to sick patients as quickly as possible, while also supporting research to further evaluate whether these medical countermeasures are safe and effective for treating patients infected with this new virus.“This is great news for the American people in terms of the partnership between the private sector and government,” Hahn, who has been working closely with the Trump administration to find medicines effective in fighting the coronavirus, said.CORONAVIRUS: WHAT TO KNOW“For the last four to six weeks we stood up a group to actually look at the acceleration of potential therapies, treatments

Continue To Full Article